DiappyMed
Created in 2021
Trend leader (A+)
Existing signals make this entity one of the most dynamic startupsSocial networks
2,493 463Activities
Technologies
Entity types
Location
3 Av. de l'Europe, 34830 Clapiers, France
Clapiers
France
Employees
Scale: 11-50, 2-10
Estimated: 29
SIREN
893114405Engaged corporates
18
10 13Added in Motherbase
1 year, 3 months ago
healthtech Value proposition
[Automatic translation follows] Lighten diabetes with digital tools including digital therapy to personalize insulin dosage
[FR] Diappymed is a Montpellier company specializing in supporting people with diabetes (type 1 and 2) in their daily life 🩵
Our mission is to provide simple and clinically validated digital tools to facilitate the management of diabetes: whether by nutritional information or by adjusting doses of insulin, our tools contribute daily, to a better glycemic balance*and a reduction in the mental load **:
• Ekiyou Carbs is a mobile application to count carbohydrates safe, precise and personalized
• Ekiyou is a digital therapy to calculate an insulin dose recommendation as a function of the meal, physical activity and blood sugar. It is intended for patients treated with Bolus basal diagram. Ekiyou is a class IIB medical device with CE marking (1912) and is available in France
Our tools are supported by a medical committee of diabetologists and were co-constructed with a community of 2,000 patients.
[EN] Diappymed is a french company specialized in supporting people living with diabetes (Type 1 and 2) in Their Daily Lives 🩵
Our mission is to provide simple and clinically validated digital tools for diabetes management: where through nutritional information or insulin dose Adjustments, our tools contributes to better glycemic control*and a reduced mental barden **:
• Ekiyou Carbs is a mobile app for safe, accurate, and personalized carbohydrate counting
• Ekiyou is a digital therapy that calculates insulin dose recommendations based on meals, physical activity, and glycemia. It is designed for patients treated with a basal-bolus insulin regimen. Ekiyou is a Class IIB Medical Device with this Marking (1912) and is available in France
Our tools are supported by a medical committee of diabetologists and we are co-developed with a community of 2000 patients.
*Glucal NCT026766609
** Glucal 3 NCT05098301Original language
Alléger le diabète avec des outils digitaux dont une thérapie numérique pour personnaliser le dosage d’insuline
[FR] DiappyMed est une entreprise Montpelliéraine spécialisée dans l’accompagnement des personnes atteintes de diabète (Type 1 et 2) dans leur quotidien 🩵
Notre mission est d’apporter des outils numériques simples et validés cliniquement pour faciliter la prise en charge du diabète: que ce soit par de l'information nutritionnelle ou par de l'ajustement de doses d'insuline, nos outils contribuent au quotidien, à un meilleur équilibre glycémique* et une réduction de la charge mentale**:
• EkiYou Carbs est une application mobile permettant de compter les glucides de manière sûre, précise et personnalisée
• EkiYou est une thérapie numérique permettant de calculer une recommandation de dose d'insuline en fonction du repas, de l'activité physique et de la glycémie. Elle est destinée aux patients traités par schéma basal bolus. EkiYou est un dispositif médical de classe IIb disposant du marquage CE (1912) et est disponible en France
Nos outils sont soutenus par un comité médical de diabétologues et ont été co-construits avec une communauté de 2000 patients.
[EN] DiappyMed is a French company specialized in supporting people living with diabetes (Type 1 and 2) in their daily lives 🩵
Our mission is to provide simple and clinically validated digital tools for diabetes management: whether through nutritional information or insulin dose adjustments, our tools contribute to better glycemic control* and a reduced mental burden**:
• EkiYou Carbs is a mobile app for safe, accurate, and personalized carbohydrate counting
• EkiYou is a digital therapy that calculates insulin dose recommendations based on meals, physical activity, and glycemia. It is designed for patients treated with a basal-bolus insulin regimen. EkiYou is a Class IIb medical device with CE marking (1912) and is available in France
Our tools are supported by a medical committee of diabetologists and were co-developed with a community of 2000 patients.
*GLUCAL NCT02676609
**GLUCAL 3 NCT05098301
DiappyMed allège la vie des personnes atteintes de diabète
Une thérapie numérique pour personnaliser le traitement du diabète et calculer des doses d'insuline.
https://diappymed.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Gouvernement | Other 10 Apr 2025 | | |
 France Digitale Startup accelerator & VC, Non-profit Organizations | France Digitale Startup accelerator & VC, Non-profit Organizations | Other 20 Feb 2025 | | |
 Future4Care Startup accelerator & VC | Future4Care Startup accelerator & VC | Other 4 Jan 2023 | | |
 BFM Business Media, Broadcast Media Production and Distribution | BFM Business Media, Broadcast Media Production and Distribution | Other 8 Dec 2024 | | |
 | Santé publique France | Other 21 Oct 2024 | | |
 | Incubateur IMT Mines Alès | Other 4 Jun 2024 | | |
 French Tech Méditerranée French Tech, Software Development | French Tech Méditerranée French Tech, Software Development | Other 8 Oct 2024 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 7 Apr 2025 | | |
 | SATT AxLR | Other 28 Feb 2025 | | |
 BIC de Montpellier Government Administration | BIC de Montpellier Government Administration | Other 27 Oct 2023 | | |